Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 139
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00003757 | Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy | ||
| NCT00003230 | Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia | ||
| NCT07020065 | Reduced-dose Carboplatin-doublet-chemotherapy + Cemiplimab vs Cemiplimab Monotherapy in Treatment Naive Older and Frail Patients With Metastatic NSCLC With PD-L1 <50% | ||
| NCT06358573 | Intratumoral INT230-6 Followed by Neoadjuvant Immuno-chemotherapy in Patients With Early TNBC. INVINCIBLE-4-SAKK | ||
| NCT00004873 | Combination Chemotherapy in Treating Patients With Advanced Stomach Cancer | ||
| NCT00568048 | Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery | ||
| NCT03762122 | Rogaratinib in Patients With Advanced Pretreated Squamous-cell Non-small Cell Lung Cancer (SQCLC) | ||
| NCT06284122 | Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 | ||
| NCT02467582 | Adjuvant Aspirin Treatment for Colon Cancer Patients | ||
| NCT02933801 | ODM-201 Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents. | ||
| NCT01009801 | Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer | ||
| NCT03213301 | Lurbinectedin Monotherapy in Patients With Progressive Malignant Pleural Mesothelioma. | ||
| NCT00006023 | Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy | ||
| NCT00976755 | Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer | ||
| NCT01272050 | Radiation Therapy in Treating Patients With Relapsed Prostate Cancer After Surgery | ||
| NCT01718808 | Cetuximab for Elderly Patients With mCRC | ||
| NCT06114108 | Trial Comparing Systemic Therapy Alone and With Local Ablative Treatment for Stage IV NSCL Cancer Patients | ||
| NCT00238290 | Trastuzumab and Letrozole in Treating Postmenopausal Women With Progressive Advanced Breast Cancer | ||
| NCT02311569 | Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation | ||
| NCT00003902 | Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone Involvement | ||
| NCT02572843 | Anti-PD-L1 in Stage IIIA(N2) Non-small Cell Lung Cancer (NSCLC) | ||
| NCT02311543 | Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer | ||
| NCT03937843 | Reduced Intensity Radio-chemotherapy for Stage IIA/B Seminoma | ||
| NCT03905343 | Ribociclib-endocrine Combination Therapy Versus Chemotherapy as 1st Line in Visceral mBC | ||
| NCT02910843 | Neoadjuvant Treatment With Regorafenib and Capecitabine Combined With Radiotherapy in Locally Advanced Rectal Cancer | ||
| NCT00766779 | HCT Versus CT in Elderly AML | ||
| NCT03708003 | Ibrutinib lead-in Followed by Venetoclax Plus Ibrutinib in Patients With RR CLL | ||
| NCT00227695 | Rituximab in Treating Patients With Follicular Non-Hodgkin's Lymphoma | ||
| NCT00003779 | Biological Therapy in Treating Patients With Bladder Cancer | ||
| NCT01926964 | Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer | ||
| NCT01555281 | Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma | ||
| NCT00003746 | Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia | ||
| NCT00030810 | Combination Chemotherapy Followed by Radiation Therapy Before Surgery in Treating Patients With Stage IIIB NSCLC | ||
| NCT00238381 | Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer | ||
| NCT04480372 | SAKK 17/18 (ORIGIN) MPM & NSCLC >1st Line Gemci & Atezo Ph II | ||
| NCT00516412 | Everolimus in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma | ||
| NCT03620669 | 1st Line Durvalumab in PS 2 NSCLC Patients | ||
| NCT04629781 | Open-label Dose Escalation Phase 1b Trial of a New Micellar Docetaxel Compound in Patients With mCRPC | ||
| NCT00004208 | Antithymocyte Globulin and Cyclosporine in Treating Patients With Myelodysplastic Syndrome | ||
| NCT02964689 | Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC. | ||
| NCT00003231 | Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer | ||
| NCT00020566 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma | ||
| NCT01707966 | Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | ||
| NCT02833766 | Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer | ||
| NCT00777894 | Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery | ||
| NCT06090162 | LIBERTY: Liquid Biopsy to Diagnose and Monitor CNS Involvement in High-risk B Cell Non-Hodgkin Lymphoma | ||
| NCT04604067 | Assessing a ctDNA and PET-oriented Therapy in Patients With DLBCL A Multicenter, Open-label, Phase II Trial. | ||
| NCT03017326 | Paediatric Hepatic International Tumour Trial | ||
| NCT00234026 | Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma | ||
| NCT00002526 | Chemotherapy in Treating Patients With Advanced Sarcoma |
